Fraudulent Misrepresentation and Fraudulent Concealment in Products Liability in Tort Law in Canada: The Special Relationship Between Drug Companies and Consumers in the Context of the Fraudulent Misrepresentation and Fraudulent Concealment of Data
-
Published:2020
Issue:
Volume:
Page:161-215
-
ISSN:2509-7873
-
Container-title:Accounting, Finance, Sustainability, Governance & Fraud: Theory and Application
-
language:
-
Short-container-title:
Publisher
Springer Singapore
Reference101 articles.
1. Abramson, J., & Starfield, B. (2005). The effect of conflict of interest on biomedical research and clinical practice guidelines: Can we trust the evidence in evidence-based medicine? Journal of the American Board of Family Medicine, 18(5), 414–418.
2. American Law Institute. Restatement (Third) of Agency (2006).
3. Angell, M. (2008). Industry-sponsored clinical research: A broken system. Journal of the American Medical Association, 300(9), 1069–1071.
4. Aursnes, I., & Klemp Gjertsen, M. (2008). Common adverse events associated with an SSRI: Meta analysis of early paroxetine data. Pharmacoepidemiology and Drug Safety, 17, 707–713.
5. Aursnes, I., Tvete, I. F., Gassemyr, J., & Natvig, B. (2005). Suicide attempts in clinical trials with paroxetine randomised against placebo. BMC Medicine, 3(14), 5.